At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies.
IN CASE YOU MISSED IT
- 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
- Medicina recalls IV Luer Slip syringes
- Eitan Group signs service agreement with Integrated Medical Systems
- Beta Bionics’ bionic pancreas wins breakthrough status from FDA
- FDA details framework for abbreviated 510(k) medical device review pathway